Published • loading... • Updated
Eli Lilly announces $6.5B manufacturing plant in Houston, boosting investment from initial proposal
Eli Lilly's $6.5 billion Houston facility will create 615 permanent jobs and 4,000 construction roles to produce small molecule medicines including the oral obesity drug orforglipron.
- Eli Lilly plans to build a new $6.5 billion manufacturing facility for small molecule drugs in Houston, Texas.
- The facility will focus on producing Eli Lilly's potential obesity and diabetes drug orforglipron and create 615 new jobs in the area.
- Construction on the 236-acre site is expected to begin this year and be completed within 5 years, generating around 4,000 construction jobs.
Insights by Ground AI
42 Articles
42 Articles
Eli Lilly to Construct $6.5 Billion Manufacturing Facility in Houston
Pharmaceutical giant Eli Lilly and Company has announced plans to build a $6.5 billion manufacturing facility in Houston and is expected to create more than 4,600 manufacturing and construction jobs. Construction at the city’s Generation Park is slated to begin in 2026 and become fully operational by 2031. In a Sept. 23 statement, Lilly revealed it will be manufacturing next-generation synthetic medicine active pharmaceutical products at the Hou…
·New York, United States
Read Full ArticleEli Lilly announces weight-loss drug to be manufactured at $6.5 billion site in Houston
The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing hub is slated to be built at Generation Park near Lake Houston and will produce a new weight-loss drug.
·Houston, United States
Read Full ArticleCoverage Details
Total News Sources42
Leaning Left1Leaning Right1Center19Last UpdatedBias Distribution90% Center
Bias Distribution
- 90% of the sources are Center
90% Center
C 90%
Factuality
To view factuality data please Upgrade to Premium